Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI™ (lecanemab-irmb) for the Treatment of Alzheimer's Disease
ADDF STATEMENT ON FDA ACCELERATED APPROVAL OF LECANEMAB (LEQEMBI)
Ligand's Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
Global Spinal Muscular Atrophy Treatment Market Report 2022: Growing R&D Activities for Treatments Boosts Sector - ResearchAndMarkets.com
BiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Global Spinal Muscular Atrophy Treatment Market Report 2022: Increasing Reimbursement Access To Patients Bolsters Growth
 14   15   16   17   18     19    20   21   22   23   24 
 <<   <   >   >>